1. Targeted maximum likelihood estimation in safety analysis.
- Author
-
Lendle, Samuel D., Fireman, Bruce, and van der Laan, Mark J.
- Subjects
- *
MEDICATION safety , *HYPOGLYCEMIC agents , *MYOCARDIAL infarction treatment , *REGRESSION analysis , *ESTIMATION theory - Abstract
Objectives: To compare the performance of a targeted maximum likelihood estimator (TMLE) and a collaborative TMLE (CTMLE) to other estimators in a drug safety analysis, including a regression-based estimator, propensity score (PS)ebased estimators, and an alternate doubly robust (DR) estimator in a real example and simulations. Study Design and Setting: The real data set is a subset of observational data from Kaiser Permanente Northern California formatted for use in active drug safety surveillance. Both the real and simulated data sets include potential confounders, a treatment variable indicating use of one of two antidiabetic treatments and an outcome variable indicating occurrence of an acute myocardial infarction (AMI). Results: In the real data example, there is no difference in AMI rates between treatments. In simulations, the double robustness property is demonstrated: DR estimators are consistent if either the initial outcome regression or PS estimator is consistent, whereas other estimators are inconsistent if the initial estimator is not consistent. In simulations with near-positivity violations, CTMLE performs well relative to other estimators by adaptively estimating the PS. Conclusion: Each of the DR estimators was consistent, and TMLE and CTMLE had the smallest mean squared error in simulations. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF